Registration of securities issued in business combination transactions

Restatement of Previously issued Financial Statements - Summary Of Effect Of Restatement On Financial Statement (Detail)

v3.21.2
Restatement of Previously issued Financial Statements - Summary Of Effect Of Restatement On Financial Statement (Detail) - USD ($)
 3 Months Ended 5 Months Ended
Mar. 31, 2021
Dec. 31, 2020
Nov. 27, 2020
Nov. 26, 2020
Jul. 28, 2020
Balance Sheet at :          
Warrant liability $ 36,104,088 $ 36,549,753   $ 36,549,753  
Total liabilities 42,030,071 42,409,421      
Additional paid-in capital 17,000,551 17,260,671      
Accumulated deficit (12,001,400) (12,261,549)      
Total Shareholders' Equity 5,000,010 5,000,006     $ 0
Statement of Operations for the period from July 29, 2020 (inception) through December 31, 2020          
Excess of fair value of Private Placement Warrants 445,665 (11,211,642)      
Transaction costs   1,021,001      
Total other income/(expense) 474,123 (12,221,892)      
Net loss 260,149 (12,261,549)      
Cash Flows from Operating Activities:          
Net loss 260,149 (12,261,549)      
Excess value of underwriter warrants (445,665) 11,211,642      
Net cash used in operating activities (108,852) (97,168)      
Supplemental disclosure of cash flow information:          
Class A ordinary shares subject to possible redemption $ (260,145) (21,295)      
Initial classification of warrant liability   36,549,753      
As Previously Reported [Member]          
Balance Sheet at :          
Total liabilities   5,859,668 $ 5,680,163    
Class A ordinary shares subject to possible redemption   156,864,332 156,885,627    
Class A ordinary shares   93 92    
Additional paid-in capital   5,028,387 5,007,093    
Accumulated deficit   (28,906) (7,611)    
Total Shareholders' Equity   5,000,005 5,000,005    
Statement of Operations for the period from July 29, 2020 (inception) through December 31, 2020          
Total other income/(expense)   10,751      
Net loss   $ (28,906)      
Basic and diluted net loss per share, Class B Ordinary shares   $ 0.00      
Cash Flows from Operating Activities:          
Net loss   $ (28,906)      
Net cash used in operating activities   (97,168)      
Supplemental disclosure of cash flow information:          
Class A ordinary shares subject to possible redemption   156,864,332      
Adjustment [Member]          
Balance Sheet at :          
Warrant liability   36,549,753 36,549,753    
Total liabilities   36,549,753 36,549,753    
Class A ordinary shares subject to possible redemption   (36,549,754) (36,549,754)    
Class A ordinary shares   360 360    
Additional paid-in capital   12,232,284 12,232,284    
Accumulated deficit   (12,232,643) (12,232,643)    
Total Shareholders' Equity   1 1    
Statement of Operations for the period from July 29, 2020 (inception) through December 31, 2020          
Excess of fair value of Private Placement Warrants   (11,211,642)      
Transaction costs   (1,021,001)      
Total other income/(expense)   (12,232,643)      
Net loss   $ (12,232,643)      
Basic and diluted net loss per share, Class B Ordinary shares   $ (3.20)      
Cash Flows from Operating Activities:          
Net loss   $ (12,232,643)      
Excess value of underwriter warrants   11,211,642      
Transaction costs   1,021,001      
Supplemental disclosure of cash flow information:          
Class A ordinary shares subject to possible redemption   (36,549,754)      
Initial classification of warrant liability   36,549,753      
As restated [Member]          
Balance Sheet at :          
Warrant liability   36,549,753 36,549,753    
Total liabilities   42,409,421 42,229,916    
Class A ordinary shares subject to possible redemption   120,314,578 120,335,873    
Class A ordinary shares   453 442    
Additional paid-in capital   17,260,671 17,239,377    
Accumulated deficit   (12,261,549) (12,240,254)    
Total Shareholders' Equity   5,000,006 $ 5,000,006    
Statement of Operations for the period from July 29, 2020 (inception) through December 31, 2020          
Excess of fair value of Private Placement Warrants   (11,211,642)      
Transaction costs   (1,021,001)      
Total other income/(expense)   (12,221,892)      
Net loss   $ (12,261,549)      
Basic and diluted net loss per share, Class B Ordinary shares   $ (3.20)      
Cash Flows from Operating Activities:          
Net loss   $ (12,261,549)      
Excess value of underwriter warrants   11,211,642      
Transaction costs   1,021,001      
Net cash used in operating activities   (97,168)      
Supplemental disclosure of cash flow information:          
Class A ordinary shares subject to possible redemption   120,314,578      
Initial classification of warrant liability   $ 36,549,753